CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 131 enrolled
Drug / intervention
ImRS +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03833531
NCT03833531N/ACompleted
CompareCT.gov

Prediction and Outcome Study in PTSD and (Cluster C) Personality Disorders

Arkin·interventional·Posted Feb 7, 2019·Updated Jun 7, 2023

In Brief

A clinical study evaluating ImRS and SFT for Posttraumatic Stress Disorder (PTSD) and 3 related conditions. Completed, enrolled 131 participants across 1 site.

Detailed Summary

The goal of PROSPER-C is to study effectiveness of ImRs compared to integrated SFT-ImRs in treatment-seeking, adult patients with comorbid PTSD and Cluster C Personality Disorder (CPD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPosttraumatic Stress Disorder (PTSD), Avoidant Personality Disorder, Dependent Personality Disorder, Obsessive Compulsive Personality Disorder
CountriesNetherlands
CollaboratorsSinai Centrum, Arkin, The Netherlands, Amsterdam UMC, location VUmc, Stichting Steunfonds Joodse Geestelijke Gezondheidszorg (SSF JGG), Ziekenhuis Amstelland, Meander Medisch Centrum

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 7, 2019
Enrollment StartJun 1, 2018
Primary CompletionJan 9, 2023
Study CompletionMay 5, 2023
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 7.4 years ago

Interventions

ImRSbehavioral

ImRs is a PTSD treatment that specifically addresses the troubling memories of the traumatic event and the personal meaning of the event and consist of 12 to 18 sessions in maximum 6 months.

SFTbehavioral

SFT is a treatment for personality disorders that takes at least one group-session per week, for the duration of one year.